LncRNA MEG3 has been characterized in CML as being capable of decreasing the expression of MDR1, MRP1, and ABCG2 by suppressing miR-21 [127]. The gene discussed is MEG3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.